Related Experiment Videos
Platelet aggregation and cyclic nucleotide phosphodiesterase activity in arteriosclerotic patients
Insights
Platelet phosphodiesterase (PDE) activity, crucial for cyclic AMP and cyclic GMP regulation, showed no significant differences in patients with arteriosclerosis. However, a notable inverse correlation between PDE activity and platelet aggregation was observed in arteriosclerotic patients, suggesting altered platelet function.
Area of Science:
- Biochemistry
- Hematology
- Cardiovascular Research
Background:
- Cyclic AMP and cyclic GMP are vital in regulating platelet aggregation.
- Limited information exists regarding the role of phosphodiesterases (PDEs) in platelet function, particularly in disease states.
Purpose of the Study:
- To investigate the activities of cyclic AMP phosphodiesterase (cAMPPDE) and cyclic GMP phosphodiesterase (cGMPPDE) in platelets.
- To examine the relationship between PDE activity and platelet aggregation in healthy individuals and patients with arteriosclerosis.
Main Methods:
- Measurement of cAMPPDE and cGMPPDE activities in platelets from healthy volunteers, arteriosclerotic patients, and miscellaneous patients.
- Assessment of platelet aggregation induced by ADP and adrenaline.
- Statistical analysis to determine correlations between PDE activity and platelet aggregability.
Main Results:
- Platelet cAMPPDE and cGMPPDE activities did not significantly differ among healthy, arteriosclerotic, and miscellaneous patient groups.
- Platelet aggregability by ADP and adrenaline showed no significant differences across the groups.
- A significant inverse correlation was found between adrenaline-induced platelet aggregation and both cAMPPDE and cGMPPDE activities exclusively in arteriosclerotic patients.
Conclusions:
- While basal PDE activities are similar, arteriosclerosis is associated with an inverse relationship between PDE activity and platelet aggregation.
- This suggests that interactions with arteriosclerotic vessel walls may induce specific changes in platelet cyclic nucleotide metabolism and function.
- Further research is warranted to elucidate the mechanisms underlying these altered platelet dynamics in arteriosclerosis.
Abstract:
Although roles of roles of cyclic AMP and cyclic GMP in platelets are though to be important on platelet aggregation, little information on their phosphodiesterase (PDE) is available. Cyclic AMP and cyclic GMP hydrolytic activities of platelets (cAMPPDE and cGMPPDE in platelets) and platelet aggregation by ADP and adrenaline were measured in 22 healthy volunteers, 26 arteriosclerotic patients and other 20 miscellaneous patients excluding vascular diseases. Activities of cAMPPDE and cGMPPDE of platelets were 2.37 +/- 0.52, 7.23 +/- 1.84 in the healthy, 2.50 +/- 0.85, 7.53 +/- 2.60 in the arteriosclerotics and 2.38 +/- 1.02, 6.98 +/- 2.59 pmol/min/10(7) platelets in the miscellaneous patients, respectively. No significant difference was observed among these three groups. Platelet aggregabilities also showed no significant difference. However, there was a significant inverse correlation between the aggregability by 1 microgram/ml of adrenaline and the PDE activities only in the arteriosclerotic patients. The correlation coefficient were-0.61 between the primary aggregation and cAMPPDE,-0.65 between the primary aggregation and cGMPPDE,-0.58 between the 5 min aggregation and cAMPPDE and -0.76 between the 5 min aggregation and cGMPPDE. The inverse correlation between platelet aggregation and cyclic nucleotide metabolism in circulating platelts of the arteriosclerotic patients may suggest that interaction of platelets with arteriosclerotiv vessel walls would produce a certain change in platelets.